Though it said there was no evidence patients are at risk.

Company: Roche didn’t review 80k side effect reports LONDON – – The European Medicines Agency is investigating ‘deficiencies’ in the way medication maker Roche reported possible unwanted effects in patients in the U.S., though it said there was no evidence patients are at risk. European authorities spotted the nagging problems throughout a routine inspection of Roche by British regulators in May. They noticed about 80,000 reports of possible side effects for medications offered in the U.S.A complete report on the 61 common names for sugar is available at the following link on the right-hand side of the web page: The result is millions of people consuming far more sugar than they must be regularly, resulting in metabolic syndrome, a classification of risk factors connected with a host of chronic illnesses. If left to perform its training course, metabolic syndrome can result in early death by means of liver failure, heart attack, blood clots and various other life-threatening conditions. Too much sugar causes persistent metabolic disease in both fat and slim people, said pediatric endocrinologist Robert Lustig, an associate of the SugarScience group and author of Fat Opportunity: Beating the Odds Against Sugar, Processed Food, Weight problems, and Disease, pointing out that weight problems is an entirely separate issue from the considerable bodily damage due to sugar consumption.